CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2015 to Q3 2025

Type / Class
Equity / Stock
Symbol
CDTX on Nasdaq
Price per share
$95.76
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
11,162
Total reported value
$1,068,585
% of total 13F portfolios
0%
Share change
+5,006
Value change
+$479,120
Number of holders
5
Price from insider filings
$95.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 5 institutional investors reported holding 11,162 shares of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX).

Institutional Holders of CIDARA THERAPEUTICS INC COM NEW - Stock (CDTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 11,162 $1,068,585 +$479,120 $95.76 5
2025 Q2 6,156 $299,872 +$299,872 $55.36 2
2024 Q3 0 $0 -$3,680 $95.76 0
2024 Q2 4,000 $3,680 -$210,710 $0.92 1
2024 Q1 234,568 $213,597 -$1,392,613 $0.92 7
2023 Q4 23,179,993 $18,404,978 -$664,259 $0.79 50
2023 Q3 24,074,750 $22,682,521 -$2,155,070 $0.94 52
2023 Q2 26,255,377 $29,668,820 -$1,146,488 $1.13 52
2023 Q1 27,108,727 $34,423,224 +$1,370,925 $1.27 52
2022 Q4 26,634,589 $20,139,425 -$163,220 $0.76 39
2022 Q3 27,071,246 $17,059,222 -$37,048 $0.63 38
2022 Q2 27,212,375 $13,293,172 -$1,659,086 $0.49 40
2022 Q1 30,310,443 $25,234,294 -$985,113 $0.83 39
2021 Q4 31,078,404 $39,465,681 +$12,358,241 $1.27 48
2021 Q3 18,444,750 $41,310,590 -$3,104,500 $2.24 48
2021 Q2 20,045,479 $40,489,347 -$3,281,186 $2.02 53
2021 Q1 21,295,412 $56,644,120 -$5,974,915 $2.66 62
2020 Q4 24,040,576 $48,079,100 -$6,739,988 $2.00 61
2020 Q3 24,088,481 $68,671,126 +$1,308,655 $2.85 64
2020 Q2 25,106,069 $92,697,628 +$12,126,390 $3.69 64
2020 Q1 22,439,168 $55,624,774 +$14,474,491 $2.48 51
2019 Q4 16,488,827 $63,314,008 +$3,476,604 $3.84 50
2019 Q3 14,467,279 $28,864,006 -$2,401,329 $2.00 34
2019 Q2 15,822,310 $26,542,005 +$2,152,321 $1.68 41
2019 Q1 16,070,639 $42,548,008 -$4,202,865 $2.65 49
2018 Q4 17,674,910 $41,473,007 -$4,944,712 $2.35 49
2018 Q3 17,262,263 $73,861,129 -$2,219,933 $4.40 59
2018 Q2 17,747,231 $89,784,168 +$21,171,828 $5.20 56
2018 Q1 13,263,019 $53,050,012 -$8,594,243 $4.00 58
2017 Q4 14,927,264 $101,509,020 +$13,533,641 $6.80 47
2017 Q3 11,198,249 $90,704,024 +$922,700 $8.10 40
2017 Q2 11,125,500 $83,440,023 -$1,713,668 $7.50 53
2017 Q1 11,448,903 $89,297,484 +$3,844,548 $7.80 51
2016 Q4 11,394,722 $118,506,278 +$22,410,751 $10.40 57
2016 Q3 7,878,814 $90,208,154 -$2,740,366 $11.45 51
2016 Q2 8,168,686 $84,214,036 -$7,110,017 $10.31 55
2016 Q1 8,816,189 $111,962,000 -$1,557,200 $12.70 42
2015 Q4 8,936,177 $153,339,825 +$3,278,563 $17.16 43
2015 Q3 6,419,154 $81,647,656 +$7,049,997 $12.72 44
2015 Q2 5,937,620 $83,244,564 +$67,243,627 $14.02 43